Low activity of circadian continuous fluorodeoxyuridine (FUDR) chemotherapy in poor prognosis metastatic renal cancer

L. Miglietta, L. Canobbio, D. Cannata, A. Curotto, F. Berti-Riboli, L. Giuliani, F. Boccardo

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)121-123
Number of pages3
JournalOncology Reports
Issue number1
Publication statusPublished - 1994

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this